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In their editorial in the Journal of Nuclear Medi-
cine in 1991 Corstens and van der Meer de-
fined the requirements of the ideal radiotracer 
for imaging focal sites of infection and inflam-
mation [1]; high uptake in infectious/inflamed 
foci, rapid background clearance, nontoxic, low 
cost and preferably discrimination between in-
fection and non-microbial inflammation. Since 
then a wide series of radiotracers has been pro-
posed for infection/inflammation imaging based 
on antibodies, cytokines, anti-microbial or 
chemotactic peptides or antibiotics. Some of 
these tracers had in vivo characteristics that 
met most of the criteria mentioned above. How-
ever, mainly due to commercial hick-ups none 
of these agents has been made commercially 
available for routine clinical use and in most 
hospitals autologous leukocytes labeled with 
111In or 99mTc, 67Ga citrate and more recently 18F
-FDG are commonly used to determine the local-
ization and the extent of infectious disease in 
patients. 
 
In the current issue of the American Journal of 
Nuclear Medicine and Molecular Imaging Pul-
lambhatla et al. report that focal bacterial infec-
tions in the lungs in mice can be visualized with 
1 2 5 I - l a b e l e d  2 ’ - f l u o ro - 2 ’ -d e o x y -1β - D -
arabinofuranosyl-5-[125I]iodouracil (125I-FIAU) [2]. 
124/5I-FIAU is a tracer that was developed for 
imaging of cells transfected with the herpes 
simplex virus 1 (HSV1) thymidine kinase re-
porter gene. This enzyme transfers a γ phos-
phate group fom ATP to the 5’ hydroxyl group of 
pyrimidine deoxynucleosides. The lipophilic 
tracer diffuses into the cell and is trapped in the 
cell with HSV1-TK activity, because the phos-
phorylated tracer cannot pass the plasma mem-
brane. 
 
In 2005 the group at Johns Hopkins University 
hypothesized that the TK gene of bacteria was 
sufficiently similar to that of the viral TK of HSV1 
that FIAU could also be phosphorylated by the 
endogenous bacterial TK [3]. In their report pub-
lished in PNAS they provided convincing evi-
dence that indeed FIAU is a substrate of E. coli 
TK. They showed that FIAU inhibited the growth 
of the wild-type bacteria, but not a TK-deficient 
strain. In mice models, focal infections induced 
by five different genera of bacteria were imaged 
with 125I-FIAU.  
 
In the present study, Pullambhatla and cowork-
ers show that the tracer can be used to monitor 
the efficacy of anti-microbial therapy, because 
the 125I-FIAU signal intensity is proportional to 
the bacterial load. It is suggested that imaging 
Am J Nucl Med Mol Imaging 2012;2(3):271-272 
www.ajnmmi.us /ISSN:2160-8407/ajnmmi1206006 
 
Invited Perspective 
FIAU: From reporter gene imaging to imaging of bacterial 
proliferation 
 
Otto C Boerman, Peter Laverman, Wim JG Oyen 
 
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 
 
Received June 26, 2012; accepted July 3, 2012; Epub July 20, 2012; Published July 31, 2012 
 
Abstract: The radioiodinated thymidine analogue, FIAU, is a tracer that has been developed for reporter gene, for cells 
that were transfected with herpes simplex virus thymidine kinase, HSV-TK. FIAU is also a specific substrate of bacte-
rial TK due to the homology between viral and bacterial TK. In this issue of AJNMMI (http://www.ajnmmi.us), Pullamb-
hatla et al. reported that the accumulation of 125I-FIAU in pulmonary infectious foci correlated with the bacterial bur-
den in the lungs. 125I-FIAU could be used to monitor the efficacy of anti-microbial therapy in mice. Potentially 124I-FIAU 
PET could be used to discriminate microbial from sterile inflammation in patients with prosthetic implants.  
 
Keywords: Infection, inflammation, reporter gene imaging, positron emission tomography (PET) 
Invite perspective 
 
 
272                                                                                          Am J Nucl Med Mol Imaging 2012;2(3):271-272 
with FIAU could be used to evaluate the efficacy 
of newly developed antibiotics. The authors 
carefully assessed the sensitivity of imaging E. 
coli with microSPECT using 125I-FIAU as a tracer: 
in the bacterial concentrations ≥ 109 CFU/ml 
could be detected. The method is less sensitive 
than the methods based on the use of fluores-
cent probes or bioluminescence, but in contrast 
to these optical imaging modalities, radionu-
clide imaging allows imaging of deep seated 
foci. The authors speculate that the sensitivity 
can be improved by exploiting the enhanced 
sensitivity of PET using 124I-FIAU as a tracer. The 
feasibility of PET imaging of bacterial infections 
with 124I-FIAU was demonstrated by the same 
group, by successfully imaging musculoskeletal 
infections in seven patients and one healthy 
subject [4]. In that study all bacterial infections 
were visualized as early as 2 h after injection of 
the tracer. Obviously, the sensitivity of 124I-FIAU 
PET for imaging bacterial infection in various 
patients suspected of focal bacterial infections 
has yet to be assessed. 
 
Most importantly, the present report shows that 
FIAU imaging can indeed discriminate between 
microbial infection and sterile inflammation, 
because tracer accumulation is dependent of 
the presence of microbial TK activity. Pulmonary 
inflammation induced by lipopolysaccharide 
(LPS) did not show enhanced tracer uptake. It 
has been claimed that 99mTc-labeled ciproflox-
acin also specifically imaged bacterial infectious 
foci, due to the specific interaction of ciproflox-
acin with bacterial DNA gyrase and topoisom-
erase IV [5]. However, several studies have 
shown that this tracer could also be retained in 
non-microbial inflammatory sites [6, 7]. Later it 
was argued that non-bacterial infection could be 
distinguished from bacterial infection by imag-
ing at two time points, however, in a Phase II 
trial it was demonstrated that this tracer 
washed-out from sites of infection as well as 
from inflammation at the same rate [8].  
 
In clinical practice there is a great need for an 
imaging agent that could (a) discriminate be-
tween microbial infection and sterile inflamma-
tion, e.g. to discriminate infection of prosthetic 
implants from the sterile inflammatory response 
in aseptic complications and (b) monitor antibi-
otic treatment by determining successful eradi-
cation of bacteria . It would be of great interest 
to determine the diagnostic accuracy of 124I-
FIAU PET in these patients. It would be a major 
step forward when clinical studies could demon-
strate that a tracer that was developed for re-
porter gene imaging could be a valuable tool for 
evaluating the presence of active bacterial in-
fection in patients. 
 
Address correspondence to: Dr. Otto C Boerman, 
Dept. Nuclear Medicine – 756, Radboud University 
Nijmegen Medical Centre - PO Box 9101 - 6500 HB 
Nijmegen - The Netherlands Tel: +31-24-3613813; 
F a x :  + 3 1 - 2 4 - 3 6 1 8 9 4 2 ;  E - m a i l : 
o.boerman@nucmed.umcn.nl 
 
References 
 
[1] Corstens F, van der Meer JWM. Chemotactic 
peptides: New locomotion for imaging of infec-
tion? J Nucl Med 1991; 32: 491-494.  
[2] Pullambhatla M, Tessler J, Beck G, Jedynak B, 
Wurthner JU, Pomper MG. [125I]FIAU imaging in 
a preclinical model of lung infection: Quantifica-
tion of bacterial load. Am J Nucl Med Mol Imag-
ing 2012; 2: 260-270. 
[3] Bettegowda C, Foss CA, Cheong I, Wang Y, Diaz 
L, Agrawal N, Fox J, Dick J, Dang LH, Zhou S, 
Kinzler W, VogelsteinB, Pomper MG. Imaging 
bacterial infections with radiolabeled 1-(2′-deoxy-
2′-fluoro-β-D-arabinofuranosyl)-5-iodouracil. Proc 
Natl Acad Sci USA 2005; 102: 1145-1150. 
[4] Diaz LA, Foss CA, Thornton K, Nimmagadda S, 
Endres CJ, Uzuner O, Seyler TM, Ulrich SK, Con-
way J, Bettegowda C, Agrawal N, Cheong I, Zhang 
X, Ladenson PW, Vogelstein BN, Mont MA, Zhou 
S, Kinzler KW, Vogelstein B, Pomper MG. Imag-
ing of Musculoskeletal Bacterial Infections by 
[124I]FIAU-PET/CT. PLoS ONE 2007; 2: e1007.  
[5] Drlica K, Zhao XK. DNA gyrase, topoisomerase 
IV, and the 4-quinolones. Microbiol Mol Biol Rev 
1997; 61: 377-392.  
[6] Dumarey N, Blocklet D, Appelboom T, Tant L, 
Schoutens A. Infecton is not specific for bacterial 
osteo-articular infective pathology. Eur J Nucl 
med Mol Imaging 2002; 29: 530-535. 
[7] Sarda L, Cremieuw AC, Lebellect Y, Meulemans 
A, Lebtahi R, Hayem G. Inability of Tc-99m-
cirprofloxacin scintigraphy to discriminate be-
tween septic and sterile osteoarticular diseases. 
J Nucl Med 2003; 44: 920-926. 
[8] Palestro CJ, Love C, Miller TT. Diagnostic imaging 
tests and microbial infections. Cell Microbiol 
2007; 9: 2323-2333.  
